WELLS FARGO & COMPANY/MN - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$590,094
+27.2%
33,972
+3.1%
0.00%
Q2 2023$463,978
+44.3%
32,953
+10.3%
0.00%
Q1 2023$321,530
+2300.9%
29,882
+3242.5%
0.00%
Q4 2022$13,392
-16.3%
894
-26.5%
0.00%
Q3 2022$16,000
+6.7%
1,217
-20.6%
0.00%
Q2 2022$15,000
-61.5%
1,532
-60.7%
0.00%
Q1 2022$39,000
-76.5%
3,894
-72.4%
0.00%
Q4 2021$166,000
-23.1%
14,123
-25.4%
0.00%
Q3 2021$216,000
-52.5%
18,925
-42.0%
0.00%
Q2 2021$455,000
-79.5%
32,636
-72.7%
0.00%
Q1 2021$2,216,000
+73.7%
119,693
+65.7%
0.00%
Q4 2020$1,276,000
+68.8%
72,215
+46.2%
0.00%
Q3 2020$756,000
-26.2%
49,403
+22.9%
0.00%
Q2 2020$1,024,000
+582.7%
40,186
+314.7%
0.00%
Q1 2020$150,000
+74.4%
9,690
+23.8%
0.00%
Q4 2019$86,000
+30.3%
7,828
+0.1%
0.00%
Q3 2019$66,000
-33.3%
7,821
+7.0%
0.00%
Q2 2019$99,000
-59.4%
7,308
-46.0%
0.00%
Q1 2019$244,000
-10.6%
13,528
+38.9%
0.00%
Q4 2018$273,000
+1087.0%
9,741
+962.3%
0.00%
Q3 2018$23,0009170.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders